Securing access for Cagrilintide 10mg and abaloparatide can be complex, as they are prescription treatments primarily prescribed for osteoporosis management in patients at significant risk for fractures. Usually, these therapies are not accessible over-the-top and demand a prescription. A physician is the initial point of contact for determining el